Zura Bio Limited - Class A – Cashflow (NASDAQ:ZURA) | MetaTrader

Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik

Vierteljährlich Jährlich

Mittelzufluss aus laufender Geschäftstätigkeit —-1.07 M-15.05 M-28.08 M-64.81 M -64.81 M Mittelzufluss aus Investitionstätigkeit ——-8 M-5.08 M-113 K -113 K Zahlungsströme aus der Finanzierungstätigkeit —355.6 K121.29 M109.84 M-2.16 M -2.16 M Freier Cashflow —-1.07 M-15.05 M-28.15 M-64.93 M -64.93 M

Nachrichten

Stock Picks From Seeking Alpha's March 2026 New Analysts

Progress Software Posts Upbeat Q4 Earnings, Joins ServisFirst Bancshares, Zura Bio And Other Big Stocks Moving Higher On Wednesday - American Resources (NASDAQ:AREC), ARM Holdings (NASDAQ:ARM)

Worthington Steel, Immunitybio, Riot Platforms, Micron Technology And Other Big Stocks Moving Higher On Friday - Ambarella (NASDAQ:AMBA), AST SpaceMobile (NASDAQ:ASTS)

Zura Bio expands HS trial, delays data readout to fourth quarter 2026

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Autolus Therapeutics (NASDAQ:AUTL), Brand Engagement Network (NASDAQ:BNAI)

DigitalBridge Group, Eightco Holdings, Palisade Bio And Other Big Stocks Moving Higher On Monday - Autolus Therapeutics (NASDAQ:AUTL), DigitalBridge Gr (NYSE:DBRG)

H.C. Wainwright reiterates Neutral rating on Zura Bio stock amid BAFF inhibitor concerns

Zura Bio names Eric Hyllengren as new CFO, effective July 7

Zura Bio to Present at the Jefferies Global Healthcare Conference

Zura Bio begins phase 2 trial for hidradenitis suppurativa treatment